CAR T-cell Therapy and Transplant: Individualized Treatment Choices and Sequencing for Optimal Outcomes (Social Worker)

Credit Available: CME, NCPD

 

Enroll in this Course

FREE

access until December 14, 2027 12:00 am

Enroll Now

Activity Description

This recorded webinar is derived from ONS Congress 2026. Earn free CE credit, as you deepen your knowledge on treatment choices for blood cancers. Focus will be on when to use CAR T-cell therapy versus Stem Cell Transplant, when to refer patients for discussion of these therapies, and important questions and answers surrounding the therapy selection and sequencing in patients with blood cancer. Through case-based discussion with audience participation, the integral role of the nurse in multidisciplinary care for safe and successful provision of transplant and cellular therapies will be covered, along with resources to educate and support your patients.

Time to Complete Activity: 1.5 hour

This course is available from:

June 1, 2026 until December 14, 2027

Course Instructors

Liffy Cherian, MSN, APRN, AGCNS-BC, OCN Speaker

Clinical Nurse Specialist, Lead APP Simmons Acute Care, Infusion Services and CTU, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX

Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP Speaker

Nurse Practitioner, Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX

Praveen Ramakrishnan, MD, MS, MBA, FACP Speaker

Associate Professor of Internal Medicine, Director of the Aggressive Lymphoma Program, Section of Hematologic Malignancies and Cellular Therapy, Division of Hematology/Oncology, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX

Behyar Zoghi, MD, PhD, FACP Speaker

Director of Longterm Clinic at Sarah Cannon, Adult Stem cell and Cellular Therapy Program, Methodist Hospital, San Antonio, TX

Ashley Giacobbi DNP, RN, ACNS-BC, AOCNS, OCN Speaker

Senior Clinical Trial Nurse Navigator, Clinical Trial Support Center, Blood Cancer United, Washington, DC

Target Audience

This CE activity is intended for oncology nurses and nurse practitioners involved in the care of patients with hematologic malignancies.

Learning Objectives
After completing this activity, the participant should be better able to:

• • Describe the principles of CAR T-cell and stem cell transplantation and best practices for management in the treatment of patients with blood cancers
  • Identify when to use CAR T-cell therapy versus stem cell transplant, when to refer patients, and how to appropriately sequence these modalities in clinical practice
  • Explain the role of the multidisciplinary team when treating patients with CAR T-cell therapy or stem cell transplant
  • Utilize educational resources on CAR T-cell therapy and stem cell transplant to support patients, caregivers, and healthcare professionals

Accreditation, Credit and Support

Nursing Continuing Professional Development

Approval for nurses has been obtained by the National Office of Blood Cancer United under Provider
Number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing. 

Social Worker Continuing Education

Blood Cancer United Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.5 clinical continuing education credits.

Blood Cancer United is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. Blood Cancer United maintains responsibility for the program. Social workers will receive 1.5 clinical CE contact hours for this activity.

ILNA Recertification Points

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas: Care Continuum (ONC, CBCN, CPHON, AOCNP), Oncology Nursing Practice (ONC), Professional Practice/Performance (BMTCN, AOCNP), Psychosocial Dimensions of Care (AOCNP, CPHON, ONC, CBCN), Symptom Management, Palliative Care, Supportive Care (ONC, CPHON, AOCNP), Treatment (OCN, CBCN, AOCNP, CPHON).
Total points: 1.5*

*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing.

Support Statement

There is no commercial support associated with this CE activity.

Providers

This activity is provided by Blood Cancer United and Medical Learning Institute Inc.

 

Disclosure of Conflicts of Interest Policy

All persons who may impact the content of a CE activity, including faculty and planners, are required to fully disclose current and recent financial relationships with commercial interests. A conflict of interest may be considered to exist if such a person has financial relationships with the grantor or any non-eligible entities (commercial interests) that may have a direct impact on the content of the program. Financial relationship is defined as being a shareholder, consultant, grant recipient, research participant, employee, and/or recipient of other financial or material support. Recent is defined as within the past 24 months. The participants in this CE activity must be made aware of any such financial relationship(s). This disclosure policy is intended to protect all parties involved from any potential conflict of interest that may arise.

Faculty Disclosures

Liffy Cherian, MSN, APRN, AGCNS-BC, OCN, does not have any financial relationships with ineligible companies.

Ashley Giacobbi DNP, RN, ACNS-BC, AOCNS, OCN, does not have any financial relationships with ineligible companies.

Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP, does not have any financial relationships with ineligible companies.

Praveen Ramakrishnan, MD, MS, MBA, FACP, has financial relationships with the following:
Advisory Board/Consultant: Acrotech Biopharma, ADC Therapeutics, Bristol Myers Squibb (BMS), Ipsen Biopharma, Kite/Gilead Pharma, Sobi

Behyar Zoghi, MD, PhD, FACP,  does not have any financial relationships with ineligible companies.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from Blood Cancer United do not have any relevant financial relationships to disclose with ineligible companies unless listed below.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated.

If you have questions regarding your certificate, please contact Nicole Dane via email at ndane@kimeglobal.com.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@Bloodcancerunited.org